Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

Antibiotic Selection

Antibiotic Selection

Production of Antibiotics

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...

Microbiota Modulation by Antibiotics

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Contrasts and similarities in the transcriptomic response to antimicrobial coinage metals in <i>Escherichia coli</i>.

Microbiology spectrum·2026

Same author

Effect of Metal Cations on Selenite Bioreduction by a Consortium of Halophilic/Halotolerant Bacteria and/or Yeast.

Environmental microbiology reports·2026

Same author

In Vitro and In Vivo Comparison of a Novel Antimicrobial Wound Hydrogel With Commercial Wound Treatments: Antimicrobial, Antibiofilm and Biocompatibility Assessment.

International wound journal·2026

Same author

Development of metals as antimicrobials: knowledge gaps and future directions.

Canadian journal of microbiology·2026

Same author

The gut-brain connection: microbes' influence on mental health and psychological disorders.

Frontiers in microbiomes·2026

Same author

Engineering biomimetic bacteria membrane-coated nanoparticles: an emerging anti-infection platform.

Materials horizons·2025

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Needed, new paradigms in antibiotic development.

Howard Ceri, Merle E Olson, Raymond J Turner

Expert Opinion on Pharmacotherapy

|April 14, 2010

Summary

This summary is machine-generated.

Biofilms, microbial communities resistant to antibiotics, require greater attention than antibiotic resistance alone. A new approach is needed for developing and using antimicrobials to effectively treat biofilm infections.

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Jun 13, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins

Published on: April 26, 2024

Area of Science:

Microbiology
Infectious Diseases
Drug Development

Background:

Antibiotic resistance receives significant attention, overshadowing the critical issue of microbial biofilm susceptibility.
Biofilms, communities of microorganisms on surfaces, exhibit inherent tolerance to antibiotics, even when individual organisms are sensitive.
This tolerance creates a disconnect in current antimicrobial development, diagnostics, and patient treatment efficacy.

Discussion:

A paradigm shift is essential in how conventional antimicrobials are used.
Next-generation antibiotics must be screened for efficacy against biofilms.
This shift impacts industry practices, regulatory approval, and clinical application.

Key Insights:

Biofilm tolerance to antibiotics is a major clinical and research challenge.
Current antimicrobial strategies are insufficient for treating biofilm-related infections.
A fundamental change in antimicrobial development and application is necessary.

Outlook:

Future research should focus on novel strategies to eradicate biofilms.
Development of diagnostics capable of detecting biofilm presence and susceptibility is crucial.
Regulatory frameworks may need to adapt to accommodate biofilm-targeting therapies.